217 / 400
MONDAY
TUESDAY
WEDNESDAY
THURSDAY
German language Session
Q&A Modul
SCIENTIFIC PROGRAMME
209
S-321
Symposium
17:00– 18:30
|
Hall Paris 2
TOPIC 2:
Mental disorders due to psychotropic
substances, behavioural addictions
Responding to the frightening reduction of
psychiatric patients life expectancy
Chairs:
Peter Lehmann, Germany
Salam Gómez, Colombia
001
Why are psychiatric drugs the third leading
cause of death after heart disease and cancer?
Peter C. Gøtzsche, Denmark
002
Ethical and legal problems in forced admin-
istration of toxic drugs worldwide especially to a
highly vulnerable group of people
Salam Gómez, Colombia
003
Lack of information about risks and options:
innovative ways to overcome this worldwide ethical
problem in psychiatry
Darby Penney, USA
004
Psychiatric patients' needs to overcome
problems withdrawing from psychiatric drugs
Peter Lehmann, Germany
S-322
Symposium
17:00– 18:30
|
Hall Berlin 1
TOPIC 16:
Diagnostics and classification,
psychopathology, RDoC
Symptomatology and psychopathology: its signif-
icance for diagnosis, clinical practice, education,
research and complex care
Chairs:
Tsuyoshi Akiyama, Japan
Wolfgang Gaebel, Germany
001
Need of training on psychopathology/phenom-
enology in order to use DSM
Michael B. First, USA
002
WHO's scope on the necessity of training on
psychopathology/symptomatology-case vignette
method
Geoffrey M. Reed, Switzerland
003
The future of psychopathology in clinical
practice, education and research
Wolfgang Gaebel, Germany
004
Pathology of language and pathology of
affectivity in schizophrenia from “neo-kraepelinism”
to “neo-griesingerism”
Satoshi Kato, Japan
S-323
Symposium
17:00– 18:30
|
Hall Berlin 2
TOPIC 31:
Suicide and psychiatric emergencies
Best practices in suicide risk assessment
›
WPA Section: Suicidology
Chairs:
Danuta Wasserman, Sweden
Marco Sarchiapone, Italy
001
Determining suicide risk: a dream or a possibility?
Vladimir Carli, Sweden
002
Utilization of clinical biomarkers for the evalua-
tion of suicide risk
Philippe Courtet, France
003
Suicide risk assessment: where are we now?
Electrodermal activity as a possible target
Patrizia Zeppegno, Italy
004
Vulnerability to suicide by ignoring everyday
life and pain
Lars Håkan Thorell, Sweden
S-324
Symposium
17:00– 18:30
|
Hall New York 3
TOPIC 24:
Forensic psychiatry and assessment
Virtual reality applications in forensic psychiatry
Chairs:
Jürgen L. Müller, Germany
Peter Fromberger, Germany
001
Virtual reality applications in forensic psychiatry
– potentials and limitations
Jürgen L. Müller, Germany
002
Behavioral monitoring of child abusers in virtual
risk situations
Peter Fromberger, Germany
003
VRAPT – Virtual Reality Aggression Prevention
Training
Stephanie Klein Tuente, The Netherlands
004
Current projects at the ARVIPL
Sarah Michelle Neveu, Canada
S-325
Symposium
17:00– 18:30
|
Hall London 3
TOPIC 31:
Suicide and psychiatric emergencies
Suicidal and nonsuicidal self-injury in hospital treat-
ment settings: an update
Chairs:
Jagoda Pasic, USA
Heidi Combs, USA
001
Self-injury in the emergency care setting
Jagoda Pasic, USA